IL321537A - Engineered double-strand rna ligases and uses thereof - Google Patents

Engineered double-strand rna ligases and uses thereof

Info

Publication number
IL321537A
IL321537A IL321537A IL32153725A IL321537A IL 321537 A IL321537 A IL 321537A IL 321537 A IL321537 A IL 321537A IL 32153725 A IL32153725 A IL 32153725A IL 321537 A IL321537 A IL 321537A
Authority
IL
Israel
Prior art keywords
strand rna
engineered double
rna ligases
ligases
engineered
Prior art date
Application number
IL321537A
Other languages
Hebrew (he)
Inventor
Gregory Mann
Frederic Valentin Stanger
Original Assignee
Novartis Ag
Gregory Mann
Frederic Valentin Stanger
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Novartis Ag, Gregory Mann, Frederic Valentin Stanger filed Critical Novartis Ag
Publication of IL321537A publication Critical patent/IL321537A/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/11—DNA or RNA fragments; Modified forms thereof; Non-coding nucleic acids having a biological activity
    • C12N15/52—Genes encoding for enzymes or proenzymes
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • C12N15/70—Vectors or expression systems specially adapted for E. coli
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/93—Ligases (6)

Landscapes

  • Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical & Material Sciences (AREA)
  • Zoology (AREA)
  • Biomedical Technology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Wood Science & Technology (AREA)
  • Organic Chemistry (AREA)
  • General Engineering & Computer Science (AREA)
  • Biotechnology (AREA)
  • Molecular Biology (AREA)
  • Microbiology (AREA)
  • Biochemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Physics & Mathematics (AREA)
  • Biophysics (AREA)
  • Plant Pathology (AREA)
  • Medicinal Chemistry (AREA)
  • Enzymes And Modification Thereof (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Immobilizing And Processing Of Enzymes And Microorganisms (AREA)
IL321537A 2022-12-20 2025-06-16 Engineered double-strand rna ligases and uses thereof IL321537A (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP22215201 2022-12-20
PCT/IB2023/062949 WO2024134502A1 (en) 2022-12-20 2023-12-19 Engineered double-strand rna ligases and uses thereof

Publications (1)

Publication Number Publication Date
IL321537A true IL321537A (en) 2025-08-01

Family

ID=84547245

Family Applications (1)

Application Number Title Priority Date Filing Date
IL321537A IL321537A (en) 2022-12-20 2025-06-16 Engineered double-strand rna ligases and uses thereof

Country Status (10)

Country Link
EP (1) EP4638716A1 (en)
JP (1) JP2025542219A (en)
KR (1) KR20250126043A (en)
CN (1) CN120603936A (en)
AR (1) AR131405A1 (en)
AU (1) AU2023409826A1 (en)
IL (1) IL321537A (en)
MX (1) MX2025007143A (en)
TW (1) TW202440911A (en)
WO (1) WO2024134502A1 (en)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2025262452A1 (en) * 2024-06-18 2025-12-26 Novartis Ag Nucleic acid ligation method

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7629157B2 (en) 2003-08-11 2009-12-08 Codexis, Inc. Ketoreductase polypeptides and related polynucleotides
CN1845993B (en) 2003-08-28 2010-06-23 诺瓦提斯公司 Interfering RNA duplexes with blunt ends and 3' modifications
GB0608838D0 (en) 2006-05-04 2006-06-14 Novartis Ag Organic compounds
JP7613130B2 (en) * 2020-03-25 2025-01-15 味の素株式会社 Ligase mutants

Also Published As

Publication number Publication date
KR20250126043A (en) 2025-08-22
AU2023409826A1 (en) 2025-07-03
WO2024134502A1 (en) 2024-06-27
EP4638716A1 (en) 2025-10-29
CN120603936A (en) 2025-09-05
JP2025542219A (en) 2025-12-25
TW202440911A (en) 2024-10-16
MX2025007143A (en) 2025-07-01
AR131405A1 (en) 2025-03-19

Similar Documents

Publication Publication Date Title
IL308746A (en) Circular rna compositions and methods
EP4164679A4 (en) Enhanced immunogenic dna/rna compositions and methods
IL318761A (en) Oligonucleotide compositions and methods thereof
EP3668972B8 (en) Engineered dnase enzymes and use in therapy
IL311625A (en) Oligonucleotide compositions and methods thereof
GB2610711B (en) Novel engineered and chimeric nucleases
EP1750730A4 (en) Treatment of hypercholesterolemia, hypertriglyceridemia and cardiovascular-related conditions using phosphalipase-a2 inhibitors
EP4090752A4 (en) Plakophillin-2 gene therapy methods and compositions
IL325571A (en) Oligonucleotide compositions and methods thereof
PL1824775T3 (en) Debriding composition from bromelain and methods of production thereof
EP1957064A4 (en) Treatment of qt interval prolongation and diseases associated therewith
IL326042A (en) Double-stranded oligonucleotide materials and their uses
IL327343A (en) Oligonucleotide compositions and methods thereof
IL327347A (en) Oligonucleotide compositions and methods thereof
EP4100531A4 (en) Engineered bacteria and methods of producing sustainable biomolecules
IL327476A (en) Modified oligonucleotides and methods of use thereof
EP1599172A4 (en) Methods for treatment of hiv or malaria using combinations of chloroquine and protease inhibitors
GB2445651B (en) Well treatment products and methods of using them
IL316714A (en) Oligonucleotide compositions and methods thereof
IL318277A (en) Encrypted rna and methods of its use
CA3277450A1 (en) Engineered double-strand rna ligases and uses thereof
HK40129719A (en) Engineered double-strand rna ligases and uses thereof
GB202306208D0 (en) Engineered probiotics for expression of fiber-synthesizing enzymes in gut
IL321270A (en) Engineered type v rna programmable endonucleases and their uses
IL313573A (en) Engineered sirpα variants and methods of use thereof